Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer: Correlation to Therapeutic Efficacy of Cycline-Dependent Kinase Inhibitors(CDK4/6) as First Line Treatment. CYCLHER Study
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Advanced Breast Carcinoma
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS